See more : Sumuka Agro Industries Limited (SUMUKA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Health-Chem Corporation (HCLC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Health-Chem Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Churchill Resources Inc. (CRI.V) Income Statement Analysis – Financial Results
- ShinMaywa Industries, Ltd. (7224.T) Income Statement Analysis – Financial Results
- Jiangxi Lianchuang Opto-Electronic Science&Technology Co.,Ltd (600363.SS) Income Statement Analysis – Financial Results
- Loop Energy Inc. (LPEN.TO) Income Statement Analysis – Financial Results
- INDUS Holding AG (INH.DE) Income Statement Analysis – Financial Results
Health-Chem Corporation (HCLC)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
About Health-Chem Corporation
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts research and development activities for third parties on a contract basis. Health-Chem Corporation markets its products directly to wholesalers, distributors, retail pharmacy chains, mail order pharmacies, and group purchasing organizations, as well as indirectly to independent pharmacies, managed care organizations, hospitals, nursing homes, and pharmacy benefit management companies. The company was founded in 1970 and is based in Emigsville, Pennsylvania.
| Metric | 2006 | 2005 | 2004 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94M | 7.59M | 9.19M | 37.70M | 47.60M | 46.50M | 46.90M | 44.90M | 38.70M | 37.10M | 38.20M | 42.30M | 36.00M | 34.30M | 29.00M | 26.80M |
| Cost of Revenue | 5.36M | 6.45M | 6.25M | 26.80M | 31.90M | 31.50M | 30.30M | 27.90M | 25.00M | 25.20M | 25.90M | 29.20M | 24.00M | 23.40M | 18.90M | 16.90M |
| Gross Profit | 583.00K | 1.14M | 2.94M | 10.90M | 15.70M | 15.00M | 16.60M | 17.00M | 13.70M | 11.90M | 12.30M | 13.10M | 12.00M | 10.90M | 10.10M | 9.90M |
| Gross Profit Ratio | 9.81% | 15.01% | 32.03% | 28.91% | 32.98% | 32.26% | 35.39% | 37.86% | 35.40% | 32.08% | 32.20% | 30.97% | 33.33% | 31.78% | 34.83% | 36.94% |
| Research & Development | 491.00K | 438.00K | 414.00K | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.93M | 2.63M | 1.65M | 9.70M | 15.10M | 12.80M | 12.10M | 12.80M | 12.40M | 11.10M | 13.10M | 12.30M | 11.10M | 21.10M | 9.80M | 12.00M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.42M | 3.07M | 2.06M | 14.30M | 17.10M | 14.60M | 13.70M | 14.30M | 13.90M | 12.70M | 14.80M | 13.80M | 12.20M | 22.30M | 10.90M | 13.30M |
| Cost & Expenses | 7.78M | 9.52M | 8.31M | 41.10M | 49.00M | 46.10M | 44.00M | 42.20M | 38.90M | 37.90M | 40.70M | 43.00M | 36.20M | 45.70M | 29.80M | 30.20M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 805.00K | 908.00K | 909.00K | 0.00 | 1.30M | 1.40M | 1.30M | 1.50M | 2.10M | 2.60M | 2.60M | 1.70M | 600.00K | 0.00 | 600.00K | 100.00K |
| Depreciation & Amortization | 316.00K | 316.00K | 326.00K | 2.00M | 2.00M | 1.80M | 1.60M | 1.50M | 1.50M | 1.60M | 1.70M | 1.50M | 1.10M | 1.20M | 1.10M | 1.30M |
| EBITDA | -522.00K | -1.27M | 1.50M | -1.40M | 600.00K | 1.70M | 3.90M | 3.00M | 1.30M | 800.00K | -800.00K | 800.00K | 900.00K | -10.20M | 300.00K | -2.10M |
| EBITDA Ratio | -25.64% | -21.30% | 13.16% | -4.77% | 0.21% | 3.66% | 8.32% | 6.68% | -5.94% | -8.63% | 16.49% | -3.78% | -1.94% | -21.57% | -8.62% | -13.06% |
| Operating Income | 2.64M | 2.84M | 25.00K | -3.80M | -1.90M | -100.00K | 2.30M | 1.50M | -3.80M | -4.80M | 4.60M | -3.10M | -1.80M | -8.60M | -3.60M | -4.80M |
| Operating Income Ratio | 44.51% | 37.44% | 0.27% | -10.08% | -3.99% | -0.22% | 4.90% | 3.34% | -9.82% | -12.94% | 12.04% | -7.33% | -5.00% | -25.07% | -12.41% | -17.91% |
| Total Other Income/Expenses | -4.29M | -5.33M | 244.00K | -1.10M | -700.00K | -400.00K | -700.00K | -300.00K | 1.50M | 1.50M | -9.50M | -900.00K | 900.00K | -3.00M | 2.10M | 1.50M |
| Income Before Tax | -1.64M | -2.49M | 269.00K | -4.50M | -2.10M | 400.00K | 2.20M | 2.40M | 1.30M | 700.00K | -12.00M | -1.60M | 700.00K | -14.40M | 1.30M | -1.90M |
| Income Before Tax Ratio | -27.66% | -32.84% | 2.93% | -11.94% | -4.41% | 0.86% | 4.69% | 5.35% | 3.36% | 1.89% | -31.41% | -3.78% | 1.94% | -41.98% | 4.48% | -7.09% |
| Income Tax Expense | 13.00K | 897.00K | 1.17M | -1.20M | -800.00K | 700.00K | 800.00K | -200.00K | -400.00K | 200.00K | -3.70M | -600.00K | -1.30M | 200.00K | 400.00K | -800.00K |
| Net Income | -1.66M | -2.48M | 9.00K | -3.30M | -1.30M | -300.00K | 1.40M | 2.70M | 1.90M | 500.00K | -8.30M | -1.70M | 1.40M | -15.10M | 600.00K | -1.10M |
| Net Income Ratio | -27.88% | -32.69% | 0.10% | -8.75% | -2.73% | -0.65% | 2.99% | 6.01% | 4.91% | 1.35% | -21.73% | -4.02% | 3.89% | -44.02% | 2.07% | -4.10% |
| EPS | -0.14 | -0.22 | 0.00 | -0.41 | -0.17 | -0.04 | 0.18 | 0.34 | 0.35 | 0.06 | -1.17 | -0.15 | 0.21 | -2.12 | 0.09 | -0.16 |
| EPS Diluted | -0.14 | -0.22 | 0.00 | -0.41 | -0.17 | -0.04 | 0.18 | 0.34 | 0.35 | 0.06 | -1.17 | -0.15 | 0.21 | -2.12 | 0.09 | -0.16 |
| Weighted Avg Shares Out | 11.44M | 11.44M | 11.44M | 8.05M | 7.65M | 7.50M | 7.78M | 7.94M | 5.43M | 8.33M | 7.09M | 11.33M | 6.67M | 7.12M | 6.67M | 6.88M |
| Weighted Avg Shares Out (Dil) | 11.44M | 11.44M | 11.44M | 8.05M | 7.65M | 7.50M | 7.78M | 7.94M | 5.43M | 8.33M | 7.09M | 11.33M | 6.67M | 7.12M | 6.67M | 6.88M |
Source: https://incomestatements.info
Category: Stock Reports